More News

13 Jun 2007 CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
12 Jun 2007 Merck Signs Strategic Alliance With Archemix
12 Jun 2007 Biotec Pharmacon enters Phase III with the diabetic ulcers indication
12 Jun 2007 NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
12 Jun 2007 Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
12 Jun 2007 Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
12 Jun 2007 Archemix and Takeda to Enter into Collaboration for
12 Jun 2007 Coley Pharmaceutical Group Broadens Leading Toll-like Receptor (TLR) Platform Through Strategic Acquisition of 3M Company's TLR Therapeutic Research and Development Programs
09 Jun 2007 Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
08 Jun 2007 Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
08 Jun 2007 BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
08 Jun 2007 BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
08 Jun 2007 Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin(R)
07 Jun 2007 Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
07 Jun 2007 Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
06 Jun 2007 Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
06 Jun 2007 Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
05 Jun 2007 Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
03 Jun 2007 ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
02 Jun 2007 Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co.
02 Jun 2007 Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
02 Jun 2007 Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
01 Jun 2007 Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
01 Jun 2007 Wockhardt gets US FDA nod to enter the $680 million Lamisil market
01 Jun 2007 Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top